NovelStem International Corp. (NSTM)
USD 0.01
(23.46%)
USD 0.01
(23.46%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.18 Million USD | -451.56% |
| 2022 | -765.73 Thousand USD | 43.38% |
| 2021 | -1.35 Million USD | -147.96% |
| 2020 | -545.43 Thousand USD | 0.0% |
| 2013 | 6.25 Million USD | -39.93% |
| 2012 | 10.4 Million USD | 251.69% |
| 2011 | -6.86 Million USD | -239.89% |
| 2010 | 4.9 Million USD | 187.28% |
| 2009 | -5.62 Million USD | 66.66% |
| 2008 | -16.85 Million USD | -1071.76% |
| 2007 | 1.73 Million USD | -81.78% |
| 2006 | 9.52 Million USD | 206.84% |
| 2005 | -8.91 Million USD | 23.15% |
| 2004 | -11.59 Million USD | -55.85% |
| 2003 | -7.44 Million USD | 90.87% |
| 2002 | -81.55 Million USD | -94.96% |
| 2001 | -41.82 Million USD | 19.32% |
| 2000 | -51.84 Million USD | -109.91% |
| 1999 | -24.7 Million USD | -130.84% |
| 1998 | -10.7 Million USD | -256.67% |
| 1997 | -3 Million USD | 55.22% |
| 1996 | -6.7 Million USD | 20.24% |
| 1995 | -8.4 Million USD | -42.37% |
| 1994 | -5.9 Million USD | -555.56% |
| 1993 | -900 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -302.62 Thousand USD | 0.22% |
| 2024 Q1 | -303.28 Thousand USD | -1926.44% |
| 2023 Q1 | -268.82 Thousand USD | 45.74% |
| 2023 FY | -4.22 Million USD | -451.56% |
| 2023 Q2 | -2.87 Million USD | -969.4% |
| 2023 Q4 | 16.6 Thousand USD | 101.51% |
| 2023 Q3 | -1.09 Million USD | 61.86% |
| 2022 Q3 | -295.27 Thousand USD | -74.37% |
| 2022 FY | -765.73 Thousand USD | 43.38% |
| 2022 Q1 | -217.46 Thousand USD | 64.33% |
| 2022 Q2 | -169.33 Thousand USD | 22.13% |
| 2022 Q4 | -495.44 Thousand USD | -67.79% |
| 2021 Q4 | -609.73 Thousand USD | -83.81% |
| 2021 Q3 | -331.71 Thousand USD | -73.14% |
| 2021 Q2 | -191.58 Thousand USD | -62.47% |
| 2021 FY | -1.35 Million USD | -147.96% |
| 2021 Q1 | -117.91 Thousand USD | 0.0% |
| 2020 FY | -545.43 Thousand USD | 0.0% |
| 2013 Q2 | -43.03 Thousand USD | 85.09% |
| 2013 Q3 | 8.21 Million USD | 19182.25% |
| 2013 Q4 | -1.62 Million USD | -119.81% |
| 2013 Q1 | -288.68 Thousand USD | -102.44% |
| 2013 FY | 6.25 Million USD | -39.93% |
| 2012 FY | 10.4 Million USD | 251.69% |
| 2012 Q3 | -476.35 Thousand USD | 11.16% |
| 2012 Q1 | -412.53 Thousand USD | -1163.0% |
| 2012 Q4 | 11.83 Million USD | 2584.42% |
| 2012 Q2 | -536.2 Thousand USD | -29.98% |
| 2011 FY | -6.86 Million USD | -239.89% |
| 2011 Q3 | -5.41 Million USD | -4313.47% |
| 2011 Q2 | 128.61 Thousand USD | 107.98% |
| 2011 Q1 | -1.61 Million USD | -128.19% |
| 2011 Q4 | 38.8 Thousand USD | 100.72% |
| 2010 Q2 | 206.43 Thousand USD | 135.24% |
| 2010 Q3 | -429.46 Thousand USD | -308.04% |
| 2010 Q4 | 5.71 Million USD | 1430.61% |
| 2010 FY | 4.9 Million USD | 187.28% |
| 2010 Q1 | -585.82 Thousand USD | -52.22% |
| 2009 Q3 | -348.99 Thousand USD | 92.72% |
| 2009 Q2 | -4.79 Million USD | -5119.99% |
| 2009 FY | -5.62 Million USD | 66.66% |
| 2009 Q1 | -91.85 Thousand USD | 98.61% |
| 2009 Q4 | -384.85 Thousand USD | -10.28% |
| 2008 FY | -16.85 Million USD | -1071.76% |
| 2008 Q4 | -6.62 Million USD | -4.31% |
| 2008 Q3 | -6.34 Million USD | -764.64% |
| 2008 Q2 | -734.36 Thousand USD | 76.68% |
| 2008 Q1 | -3.14 Million USD | -69.38% |
| 2007 Q2 | -1.44 Million USD | 52.88% |
| 2007 Q1 | -3.06 Million USD | -79.88% |
| 2007 Q4 | -1.85 Million USD | -122.96% |
| 2007 FY | 1.73 Million USD | -81.78% |
| 2007 Q3 | 8.09 Million USD | 661.44% |
| 2006 Q3 | 14.96 Million USD | 1541.29% |
| 2006 FY | 9.52 Million USD | 206.84% |
| 2006 Q4 | -1.7 Million USD | -111.37% |
| 2006 Q2 | -1.03 Million USD | 61.58% |
| 2006 Q1 | -2.7 Million USD | -90.11% |
| 2005 Q3 | -2.51 Million USD | -25.34% |
| 2005 FY | -8.91 Million USD | 23.15% |
| 2005 Q4 | -1.42 Million USD | 43.47% |
| 2005 Q2 | -2 Million USD | 32.47% |
| 2005 Q1 | -2.97 Million USD | 24.12% |
| 2004 Q1 | -1.65 Million USD | -337.45% |
| 2004 Q2 | -1.23 Million USD | 25.5% |
| 2004 Q4 | -3.91 Million USD | 18.29% |
| 2004 Q3 | -4.79 Million USD | -288.3% |
| 2004 FY | -11.59 Million USD | -55.85% |
| 2003 Q2 | -1.85 Million USD | 35.86% |
| 2003 Q3 | -2.32 Million USD | -25.19% |
| 2003 Q4 | -378.66 Thousand USD | 83.68% |
| 2003 FY | -7.44 Million USD | 90.87% |
| 2003 Q1 | -2.88 Million USD | 32.87% |
| 2002 Q1 | -7.53 Million USD | 56.35% |
| 2002 Q2 | -6.93 Million USD | 7.98% |
| 2002 Q4 | -4.3 Million USD | 93.14% |
| 2002 Q3 | -62.77 Million USD | -805.28% |
| 2002 FY | -81.55 Million USD | -94.96% |
| 2001 Q4 | -17.26 Million USD | -114.82% |
| 2001 FY | -41.82 Million USD | 19.32% |
| 2001 Q2 | -8.37 Million USD | -5.12% |
| 2001 Q1 | -7.96 Million USD | 59.68% |
| 2001 Q3 | -8.03 Million USD | 4.04% |
| 2000 Q4 | -19.75 Million USD | -77.02% |
| 2000 Q2 | -11.75 Million USD | -28.11% |
| 2000 FY | -51.84 Million USD | -109.91% |
| 2000 Q1 | -9.17 Million USD | 39.24% |
| 2000 Q3 | -11.16 Million USD | 5.03% |
| 1999 Q1 | -1 Million USD | 76.74% |
| 1999 Q4 | -15.1 Million USD | -190.38% |
| 1999 Q3 | -5.2 Million USD | -48.57% |
| 1999 Q2 | -3.5 Million USD | -250.0% |
| 1999 FY | -24.7 Million USD | -130.84% |
| 1998 FY | -10.7 Million USD | -256.67% |
| 1998 Q3 | -2.7 Million USD | -28.57% |
| 1998 Q2 | -2.1 Million USD | -31.25% |
| 1998 Q1 | -1.6 Million USD | -900.0% |
| 1998 Q4 | -4.3 Million USD | -59.26% |
| 1997 Q4 | 200 Thousand USD | 110.53% |
| 1997 Q3 | -1.9 Million USD | -1050.0% |
| 1997 Q2 | 200 Thousand USD | 113.33% |
| 1997 Q1 | -1.5 Million USD | 25.0% |
| 1997 FY | -3 Million USD | 55.22% |
| 1996 Q1 | -1.6 Million USD | 40.74% |
| 1996 Q2 | -1.3 Million USD | 18.75% |
| 1996 FY | -6.7 Million USD | 20.24% |
| 1996 Q4 | -2 Million USD | -17.65% |
| 1996 Q3 | -1.7 Million USD | -30.77% |
| 1995 FY | -8.4 Million USD | -42.37% |
| 1995 Q1 | -2 Million USD | 31.03% |
| 1995 Q4 | -2.7 Million USD | -42.11% |
| 1995 Q3 | -1.9 Million USD | -5.56% |
| 1995 Q2 | -1.8 Million USD | 10.0% |
| 1994 Q2 | -900 Thousand USD | -125.0% |
| 1994 Q3 | -1.7 Million USD | -88.89% |
| 1994 Q4 | -2.9 Million USD | -70.59% |
| 1994 FY | -5.9 Million USD | -555.56% |
| 1994 Q1 | -400 Thousand USD | -33.33% |
| 1993 Q4 | -300 Thousand USD | -50.0% |
| 1993 Q3 | -200 Thousand USD | 0.0% |
| 1993 Q2 | -200 Thousand USD | 0.0% |
| 1993 Q1 | -200 Thousand USD | 0.0% |
| 1993 FY | -900 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | -196.972% |
| Arrayit Corporation | -3.31 Million USD | -26.291% |
| Atlantic International Corp. | -5.62 Million USD | 25.593% |
| Biocept, Inc. | -32.08 Million USD | 86.95% |
| Bioqual, Inc. | 483.48 Thousand USD | 966.073% |
| CardioGenics Holdings Inc | -1.91 Million USD | -118.507% |
| DermTech, Inc. | -100.88 Million USD | 95.85% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 100.207% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 80.609% |
| iMD Companies, Inc. | -200.63 Thousand USD | -1987.013% |
| IDenta Corp. | 14.64 Thousand USD | 28693.963% |
| Interpace Biosciences, Inc. | 802 Thousand USD | 622.107% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | 10922.973% |
| InVitro International | 1553.00 USD | 269726.529% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 51.265% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -7105.569% |
| Medical Imaging Corp. | -3.02 Million USD | -38.514% |
| Optigenex Inc. | -2.89 Million USD | -44.501% |
| PharmChem, Inc. | 845.1 Thousand USD | 595.479% |
| Proteome Sciences plc | -2.44 Million USD | -71.4% |
| Response Genetics, Inc | -20.18 Million USD | 79.254% |
| Rennova Health, Inc. | -3.29 Million USD | -27.155% |
| RushNet, Inc. | -607.02 Thousand USD | -589.803% |
| ScreenPro Security Inc. | -2.24 Million USD | -86.204% |
| Stella Diagnostics Inc. | -5.7 Million USD | 26.634% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 63.319% |
| Todos Medical Ltd. | -24.99 Million USD | 83.247% |